Tag: Dermatology

Dermatology Updates by Xagena

Medicina

Risultato immagine per xagena dermatology

DermatologyNews.net – Dermatology 

–
Newsletter :: Skin disease, Dermatology, Dermatology News, Dermatology Newsletter, AZ Guide Dermatology, Xagena Medical News, Xagena News, Xagena Medicine, Xagena Medicina, Medicine, Medicina :: Newsletter di Aggiornamento, Medicina :: Breaking News, Medicine :: Breaking News, Skin diasese :: Medical Therapy
–

Advanced basal cell …

Advanced basal cell carcinoma treated with Vismodegib, a …

Etanercept

Researchers have assessed long-term Etanercept ( Enbrel ) safety …

Combination of Tafinlar and …

Combination of Tafinlar and Mekinist in metastatic …

Apremilast

Benefits of Apremilast in patients with moderate to severe chronic …

Secukinumab

Secukinumab, an IL-17A inhibitor, for patients with moderate-to …

Erivedge

Vismodegib for treatment of advanced basal cell carcinoma …

Metastatic melanoma

Metastatic melanoma: preliminary PLX4032 phase 2 data …

Topical acne products …

Topical acne products containing the active ingredients Benzoyl …

Enbrel

Researchers have assessed long-term Etanercept ( Enbrel ) safety …

Oral Tofacitinib reverses …

Oral Tofacitinib reverses alopecia universalis in a patient with …
, , , , , , , , , , , , , ,

Dermatology Updates by Xagena

Medicina

Risultato immagine per dermatology tiscali

Dermatology – DermatologyNews.net

–
Dermatologia, Skin Disease, Dermatology, Dermatology Newsletter, Newsletter Dermatologia, Dermatologia Newsletter,  AZ GuideMedicine, AZ Guide Dermatology, PharmAlert :: Pharmacovigilance in Dermatology, Dermatology :: Therapy, Skin Disease :: Therapy, 
–
Advanced basal cell …

Advanced basal cell carcinoma treated with Vismodegib, a …
Oral Tofacitinib reverses …

Oral Tofacitinib reverses alopecia universalis in a patient with …
Treatment of patients with …

Treatment of patients with plaque-type … of chronic plaque-type …
IL-17A inhibitor

Secukinumab, IL-17A inhibitor, is significantly superior to …
Anti-TNF-alpha therapy …

Anti-TNF-alpha therapy: Adalimumab improves insulin …
Etanercept

Secukinumab, IL-17A inhibitor, is significantly superior to …
Secukinumab

Secukinumab, IL-17A inhibitor, is significantly superior to …
Enbrel

Researchers have assessed long-term Etanercept ( Enbrel ) safety …
, , , , , , , , , , , ,

Dermatology News by Xagena

Medicina

Dermatology – DermatologyNews.net

Dermatology, Skin Therapy, DermatologyNews.net, Dermatology Newsletter, Dernatology Updates, Xagena Newsletter, Xagena Medical News, Psoriasis Newsletter, AZ Guide in Dermatology, Psoriasis :: Therapy, American Academy of Dermatology Report, Dermatology Continuing Medical Education, Dermatology CME, 
–
Corticosteroids

Chronic skin disease: most patients receiving prolonged …
Treatment of patients

Treatment of patients with plaque-type psoriasis: Methotrexate …
Elidel

Eczema: Elidel and Protopic should be used cautiously. The …
Nivolumab

Nivolumab with vaccine in Ipilimumab-refractory or -naive …
Enbrel

New indication for Enbrel: psoriatic arthritis. FDA ( Food and Drug …
Opdivo

Search results for “Opdivo” … clinical activity with …
Dupilumab

Results from a phase 2b dose-ranging study of Dupilumab, an …
Ixekizumab

Ixekizumab, an anti-IL-17 monoclonal antibody, met …
IL-17A inhibitor

Secukinumab, IL-17A inhibitor, is significantly superior to …
Minoxidil

Treatment of androgenetic alopecia: Minoxidil 2% versus …
, , , , , , , , , , , , ,